Craig Anderson
The George Institute · Fudan University · Study Principal Investigator
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
18
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
3 more share only the name and are not shown
Trial papers
513
PubMed author-name match
Trials
Studies that name Craig Anderson as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 19:07 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07906275 · INTRA-ARTERIAL MeVO TREATMENT (IMP-ACT) Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632University of Calgary · not yet recruiting · Stroke, Acute Ischemic, Medium Vessel Occlusion · principal investigator
- Ph3NCT07687056 · ACT-GLOBAL IA Thrombolysis(ACT-REACT-004)Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632University of Calgary · recruiting · Stroke, Acute Ischemic, Endovascular Thrombectomy, Acute Ischemic Stroke AIS · principal investigator
- Ph3NCT06773364 · Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke TrialShanghai East Hospital · recruiting · Suspected Stroke · principal investigator
- N/ANCT06352619 · Third Enhanced Control of Hypertension and Thrombectomy Stroke Domain Within ACT-GLOBAL Adaptive Platform TrialThe George Institute · recruiting · Ischemic Stroke, Acute · principal investigator
- Ph3NCT06352632 · ACT-GLOBAL Adaptive Platform Trial for StrokeThe George Institute · recruiting · Stroke · principal investigator
- Ph3NCT06320431 · ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632University of Calgary · recruiting · Acute Ischemic Stroke AIS, Stroke Acute, Stroke, Acute, Stroke Ischemic · principal investigator
- N/ANCT05483595 · An Examination of Blinding for Chinese Herbal Oral Liquid and Matched PlaceboGuangzhou University of Traditional Chinese Medicine · completed · Placebo Evaluate · principal investigator
- N/ANCT05326932 · Large Artery Occlusion Treated in Extended Time With Mechanical Thrombectomy TrialLili SONG · completed · Acute Ischemic Stroke · principal investigator
- Ph3NCT05066620 · Chinese Herbal Medicine in Acute INtracerebral Haemorrhage (CHAIN) TrialGuangzhou University of Traditional Chinese Medicine · unknown · Intracerebral Hemorrhage · principal investigator
- Ph3NCT04904536 · Statin TReatment for COVID-19 to Optimise NeuroloGical recovERyThe George Institute · active not recruiting · Neurocognitive Impairment, Mild · principal investigator
- N/ANCT04157231 · Essential Acute Stroke Care in Low Resource Settings: a Pilot studYThe George Institute · not yet recruiting · Acute Stroke · principal investigator
- N/ANCT04140110 · Second Enhanced Control of Hypertension and Thrombectomy Stroke Study (ENCHANTED2)The George Institute for Global Health, China · terminated · Acute Ischemic Stroke · principal investigator
- Ph3NCT03790800 · Intensive Ambulance-delivered Blood Pressure Reduction in Hyper-Acute Stroke TrialThe George Institute for Global Health, China · completed · Stroke, Acute, Cerebrovascular Disorders · principal investigator
- Ph3NCT03785067 · Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-StudyThe George Institute · terminated · Cognitive Decline, Intracerebral Hemorrhage, Dementia, Vascular · principal investigator
- N/ANCT03783754 · Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial Magnetic Resonance Imaging Sub-studyThe George Institute · terminated · Stroke, Cerebral Small Vessel Diseases, Intracerebral Hemorrhage · principal investigator
- Ph3NCT02699645 · Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts TrialThe George Institute · completed · Intracerebral Haemorrhage (ICH), Hypertension · principal investigator
- N/ANCT00716079 · The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage TrialThe George Institute · completed · Intracerebral Hemorrhage, Stroke, Hypertension · principal investigator
- N/ANCT00226096 · Intensive Blood Pressure Reduction in Acute Cerebral HaemorrhageThe George Institute · completed · CVA (Cerebrovascular Accident), Cerebral Hemorrhage, Intracranial Hemorrhages · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 19:07 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 19:07 UTC. The ranking covers the 200 most relevant of 513 PubMed records, and a shared surname and initials can bring in a namesake. All 513 on PubMed
- Telmisartan, ramipril, or both in patients at high risk for vascular events.N Engl J Med · 20082,599 citationsRCR 70.9
- Treatment of hypertension in patients 80 years of age or older.N Engl J Med · 20082,119 citationsRCR 57.9
- CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea.N Engl J Med · 20161,631 citationsRCR 69.8
- Endovascular therapy after intravenous t-PA versus t-PA alone for stroke.N Engl J Med · 20131,416 citationsRCR 54.1
- 1,191 citationsRCR 42.1
- 768 citationsRCR 40.5
- Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.N Engl J Med · 1986677 citationsRCR 27.0
- Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial.Lancet Neurol · 2008591 citationsRCR 17.4
- 402 citationsRCR 16.8
- A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45).J Clin Oncol · 2022371 citationsRCR 24.8